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Abstract
Parkin is an RBR E3 ubiquitin ligase that is implicated in the development of Parkinson’s
Disease. Its ligase activity is specific for mitochondrial proteins, recognizing, tagging and
signalling mitochondria to the autophagosome for degradation. Parkin contains eight Zn2+
binding sites and a total of 35 cysteines, which are especially susceptible to oxidative
modification. Hallmarks of Parkinson’s Disease is oxidative stress and an increase of reactive
oxygen species. In this work, I used biophysical methods such as mass spectrometry, CD
spectroscopy and gel-based assays in addition to zinc and H2O2 detection methods to explore
a potentially novel redox function for parkin. This thesis shows that parkin is capable of acting
as a redox molecule, and oxidative modifications result in the liberation of two Zn2+ ions and
extensive disulfide linkage formation. Parkin ubiquitination activity is also increased by mild
oxidation but is eventually abolished. My research provides insight into novel functions of
parkin.
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Summary for Lay Audience
Proteins are essential machines inside our body that carry out a variety of roles to help keep us
healthy, aiding in digestion, growth and our immune system. When these proteins are not
functioning properly, it is possible to give rise to many illnesses and diseases. While there are
many thousands of proteins that have been discovered, an essential part of protein discovery is
to discover what the protein actually looks like. Knowing the structure of a protein can provide
very valuable information to scientists, which can in turn lead to the discovery of medicine and
therapies used to treat these diseases. In this thesis, we are interested in the shape and structure
of a protein that is sometimes the root cause of Parkinson’s Disease. We use a variety of
scientific techniques to figure out essential information of our protein of interest, which could
provide an avenue for the development of therapies used to treat patients that are diagnosed
with Parkinson’s Disease.
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Chapter 1

1

Introduction

1.1 Parkinson’s Disease
The past half-century has seen a dramatic increase in life expectancy; global life
expectancy has changed from 52 years of age in 1960 in comparison to today’s 72 years of
age (World Bank Stats). While this can be attributed to medical advancements and
increased standard of living, living longer is ironically accompanied by an assortment of
age-related diseases. Such diseases include Parkinson’s disease (PD), Alzheimer’s disease,
Huntington’s disease, Amyotrophic Lateral Sclerosis (ALS), chronic obstructive
pulmonary disease (COPD) and multiple forms of cancer, which cover a wide array of
symptoms (1). A common factor of age-related diseases is the progressive deterioration of
tissue maintenance and cellular homeostasis, leading to the development of degenerative
diseases. In particular, Parkinson’s disease is a neurodegenerative disorder of the central
nervous system, characterized by the deterioration of dopaminergic neurons of the
substantia nigra pars compacta (SNpc). James Parkinson, a British physician, first
characterized the symptoms of PD in his 1817 essay and dubbed the disease the “Shaking
Palsy”. Parkinson’s essay depicted the lives of several patients, where he documented the
classic features of PD, including tremors, an abnormal posture and gait, and muscle
weakness, as well as the progressive nature of the disease (2). Jean-Martin Charcot would
go on to further characterize the disease, distinguishing PD from other tremor-related
diseases such as multiple sclerosis, establishing distinctions between symptoms including
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rigidity, weakness and bradykinesia, and would finally name the disease after its
discoverer, Parkinson’s Disease.
Progress in understanding Parkinson’s Disease was meagre until nearly a century
later. The combined efforts of Georges Marinesco, Edouard Brissaud, Jean-Baptiste
Charcot and Paul Oscar Blocq would establish a possible link between substantia nigral
impairment with PD symptoms. Their discovery was attributed to a patient presenting with
symptoms of a unilateral PD, where after his death a tumor was found primarily impacting
the contralateral substantia nigra (SN)(3). A fortunate discovery, at a time where little
attention was paid to the SN and other brain structures were of major focus. The collective
efforts of these four researchers would be validated by Konstantin Nikolaevich Trétiakoff,
in Marinesco’s own lab, whose work cemented the idea that the loss of SN neurons gave
way to the development of Parkinson’s Disease (4). The name substantia nigra is Latin for
“black substance”, which is reflective of the structure’s increased neuromelanin levels due
to its density of dopaminergic neurons that stain and appear darker than neighboring
structures. The implication of dopaminergic neurons in PD would eventually lead to one
of the most crucial discoveries in Parkinson’s disease treatments, levodopa therapy (5).
While studies of Parkinson’s disease thus far dwelled on the pathophysiology of
the disease, one of the first biochemical links was discovered by Oleh Hornykiewicz. His
research established autopsy evidence of diminished levels of dopamine levels in striatum
of PD patients in 1960 (6). Hornykiewicz would later establish correlations between
decreasing levels of dopamine with increasing severity of PD like symptom, until finally
his work with his colleague Walther Birkmayer in 1961, where they conducted clinical
tests with levodopa (L-dopa), a dopamine analog (7). Their studies revealed L-dopa to be
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a sufficient analog and an effective treatment in alleviating Parkinson’s disease symptoms
in 20 PD patients. These results were the first piece of biochemical evidence between
dopamine and neurodegeneration, and with a long-lasting impact; L-dopa remains the most
effective drug for treatment of PD today, over 50 years after its discovery (8).
Lewy bodies (LB) were first discovered by Fritz Heinrich Lewy in 1910, who noted
unusual inclusion in the brains of patients who had neurological deficits, causing
behavioral changes in both speech and motion (9). Their relevance to PD came almost a
decade later in 1919, when Konstantin Nikolaevich Trétiakoff would establish a
relationship between the presence of LB’s in the SN and the development of PD (4). Lewy
bodies are proteinaceous inclusion bodies which are recognized as the histological
hallmark of PD. Although LB’s remain one of the major factors in the diagnosis of PD,
they remain an enigma in terms of their role in the development of PD, and further research
may provide a potential therapeutic target.
Parkinson’s disease research may still be considered in its youth; while many
breakthroughs have come about since its first description back in 1817, little headway has
been made in the disease’s genetic cause and effects. This is unsurprising, given that
sporadic cases account for over 95% of all PD cases. The first genetic description of PD
came just over 20 years ago, where a missense mutation in the long arm of chromosome 4
was documented in a family that was genetically predisposed to developing PD (10). This
mutation would present itself in the protein α-synuclein (SNCA), which would later be
implicated as the major component of Lewy Body formation and would have a monogenic
autosomal dominant phenotype. Mutations in SNCA are responsible for a severe form of
L-dopa responsive early-onset parkinsonism. This distinction created a need for a system
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of classifying PD due to the heterogenicity of genetic predispositions causing different
variations of PD. The discovery of SNCA would subsequently drive an abundance of
research in genetic cell and animal modeling of PD (11–13), leading to the discovery of
numerous other PD-related genes. While a total of 23 loci and 19 causative genes have
been identified, these genes vary greatly with regards to phenotype (PD only or PD plus
syndromes), age-at-onset (juvenile or adult onset), and inheritance mode (autosomal
dominant, recessive or X-linked) (14). Of these genes, PARK2 has garnered much focus.
The gene is implicated in the development of a recessive, early-onset form of PD and
encodes for parkin, an E3 ubiquitin ligase (15, 16). The ligase activity is essential in
modulating the ubiquitin-proteasome system and is responsible for the breakdown of
mitochondrial proteins. Parkin will be the main focus of this thesis.

1.2 Mitochondrial impairment in Parkinson’s Disease
Advances in our knowledge of mitochondrial interactions and their role in cellular
metabolism have contributed to a major progression in our understanding of many
neurodegenerative diseases. Emerging evidence has linked cellular and genetic
mitochondrial impairment to the onset of PD. Impaired mitochondrial function has become
an underlying factor in a majority of neurodegenerative disorders, which is unsurprising
given the fact that neurons have high energetic demands, thus necessitating a high
concentration of mitochondria, and that nerves lack the ability to regenerate (17).
A major breakthrough in linking Parkinson’s disease and mitochondrial impairment
occurred in 1976 as a result of an accident involving a 23-year-old chemistry grad student,
Barry Kidston. Kidston was chemically synthesizing recreational drugs and inadvertently
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created a toxic side product, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (18).
Within 3 days, Kidston would end up developing symptoms consistent with PD, which
were responsive to L-dopa treatment. After his death, an autopsy revealed several classical
indicators of PD, including deterioration of SNpc dopaminergic neurons, decreased levels
of cerebrospinal fluid (CSF) dopamine levels and the presence of LB’s within the SNpc
(19). This striking and almost instantaneous effect was later found to be caused by the
metabolism and selective destruction of neurons within the SN. MPTP is lipid soluble and
capable of crossing the blood-brain barrier, where it is metabolized by monoamine oxidaseB (MAOB) in a two-step pathway into 1-methyl-4-phenylpyridinium (MPP+), a potent
neurotoxin (Figure 1.1) (20). This toxin then accumulates within dopaminergic neurons
where it interferes with Complex I of the electron transport chain (ETC). This eventually
leads to inhibition of ATP production and stimulates superoxide radical formation, which
then subsequently leads to increased levels of reactive oxygen species (ROS) and
dopaminergic cell death (4). Kidston would soon be followed by six more similar cases, all
of whom had fallen victim to the same drug (22). MPTP not only highlighted respiratory
chain dysfunction and mitochondrial impairment as integral to the pathogenesis of PD,
researchers also saw the prospective value of MPTP as a highly selective chemical to study
nigrostriatal degeneration and the potential to induce PD in animals.
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Figure 1.1 Chemical structures of MPTP and its metabolic derivatives.
MPTP, a toxic by-product of opioid synthesis is converted to MPP+ via a two-step reaction. MPP+ is
neurotoxic and is capable to diffusing into the substantia nigra and selectively destroy dopaminergic
neurons.

Mitochondrial involvement in PD has been confirmed through the discovery of
several PD-related genes. Of the first genes implicated was α-synuclein. While its exact
function has yet to be elucidated, overexpression of wild-type SNCA, or introduction of
Ala53Thr, Glu46Lys of His50Gln mutants have been shown to induce mitochondrial
fragmentation and subsequent increase in ROS levels (23). SNCA was also shown to be
associated with mitochondria-associated membranes (MAM), creating an interface
between the endoplasmic reticulum (ER) and mitochondria for the purpose of Ca2+
signalling and apoptosis (24). DJ-1 is another protein with an unclear function, and is
related to the onset of recessive PD. However, deletion of DJ-1 has been shown to cause
similar disruptions to mitochondrial membrane potential and fragmentation pattern, which
is rescuable with the administration of glutathione as a ROS scavenging system (25).
Alternatively, the PINK1/parkin pathway is an example of two PD-related proteins that

6

have well defined functions within a mitochondrial degradation pathway. As oxidative
stress disrupts the mitochondrial membrane potential, it allows stabilization of PTEN
induced Kinase 1 (PINK1) in the outer mitochondrial membrane (OMM), which can
subsequently recruit and activate parkin on the mitochondrial periphery via its kinase
activity. Parkin then exerts its ubiquitination activity on a host of OMM and associated
proteins, thus targeting the mitochondria for degradation via mitophagy (26). In addition
to this pathway, both PINK1 and parkin also exhibit supplementary functions that are
involved in mitochondrial physiology. PINK1 is required for phosphorylation of Ser250 of
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 (NDUFA10), which
is essential for the reduction of ubiquinone in the ETC (27), while parkin has been shown
to interact with mitochondrial Stomatin-like protein 2 (SLP-2), which functions in the
assembly of respiratory chain proteins (28). Clearly, the onset of Parkinson’s disease is
very closely intertwined with mitochondrial health.

1.3 Reactive Oxygen Species and Oxidative Stress
Mitochondrial dysfunction is a hallmark of PD and inevitably leads to a disruption to the
delicate balance of the free radical equilibrium in cells. Free radicals, including ROS and
reactive nitrogen species (RNS), are a class of highly reactive molecules and are derived
from molecular oxygen or nitrogen, respectively. These include superoxides, peroxides,
hydroxides, hydroxyl radicals, and nitric oxide (NO). ROS can originate from both
endogenous sources (mitochondria, peroxisomes, ER, phagocytic cells etc.) and exogenous
sources (pollution, alcohol, tobacco smoke, heavy metals, transition metals and radiation)
(29). Oxidative stress is defined as the state in which the rate of ROS production exceeds
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the rate of ROS clearance. The generation of free radicals occurs as a by-product of natural
cellular metabolism. A free radical is defined as an atom or molecule that contains one or
more unpaired electrons in its valence shell. These radicals are highly reactive and shortlived; they are capable of attacking other molecules by scavenging an electron in order to
stabilize themselves. Increased levels of free radicals can have extensive consequences
throughout the cell, damaging a variety of macromolecules such as DNA, RNA lipids and
proteins. However, the levels of free radicals in cells must be delicately maintained, as
moderate levels of ROS/RNS have been shown to be beneficial, functioning in various
physiological functions, such as the immune system, as well as in signal transduction for
the purpose of cell proliferation, differentiation, and migration (30, 31).
The majority of cellular ROS is produced by the mitochondrion, at the site of
oxidative phosphorylation. Two components of the electron transport chain (ETC) are
responsible for superoxide radical formation: complex I (NADH dehydrogenase) and
complex III (ubiquinone cytochrome c reductase). In normal ETC function, complex I and
III utilize ubiquinone (Q), while complex I also uses flavin mononucleotide (FMN) as
cofactors in electron transfer. Complex I transfers two electrons from a reduced
nicotinamide adenine dehydrogenase (NADH) via FMN and seven FeS clusters onto
ubiquinone, generating reduced forms of FMN (FMNH2) and ubiquinone (QH2), in order
to generate a proton gradient to generate adenosine triphosphate (ATP) via oxidative
phosphorylation (32, 33). In this process, free radicals of FMN (FMNH*) and Q (QH*) are
generated. At complex I, two possible situations can occur that lead to the generation of
ROS; an excess of NADH creates a backup of electrons on FMN and the FeS clusters, or
through a process of reverse electron transfer (RET) in which electrons flow retroactively
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from complex II back to complex I via ubiquinone. Meanwhile, complex III catalyzes the
oxidation of QH2 to Q, and at this juncture, the free radical QH* is formed (34). An excess
of either (FMNH*) and (QH*) will spontaneously donate an electron to molecular oxygen
(O2), generating the superoxide free radical (O2-). As this process is non-enzymatic, the
rate is simply second order and is entirely dependent on the concentration of the free
radicals FMNH* and QH* and the availability of O2 (32).
The superoxide anion is the consider the progenitor of most reactive oxygen species
in cells, breaking down and interconverting into a majority of the ROS species present
within cells. The majority of superoxide is produced in the mitochondria, and to a much
lower extent within the cytosol, which is rapidly dismutated by mitochondrial superoxide
dismutase (MnSOD or SOD2) or by cytosolic superoxide dismutase (Cu-ZnSod or SOD1).
The enzymatic activity of SOD enzymes is considered to be ROS scavenging, as part of
the cell’s mechanism to combat increasing levels of ROS. The products of superoxide
dismutation are hydrogen peroxide (H2O2) and O2. While hydrogen peroxide is not
considered a free radical, H2O2 has been shown to cause ROS-mediated cell damage at
concentrations as low as 10 µM, while concentrations greater than 50 µM have been shown
to be cytotoxic to a variety of animal, plant and bacterial cells. Physiological steady-state
concentrations of H2O2 are maintained between 1-10 nM, while an increase in beyond
these levels is considered oxidative stress and can lead to a variety of pathologies, including
PD. H2O2 toxicity is mediated by the activity of catalase, which catalyzes the breakdown
of H2O2 to water and oxygen (27). H2O2 itself has been shown to be poorly reactive, and
does not readily react with most lipids, DNA or protein (26). H2O2 in cells has demonstrated
an important role in cellular signalling pathways such as regulating transcription, altering
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cell morphology, initiating cell proliferation and recruitment of immune cells. H2O2 acts as
a messenger through the oxidation of thiol and metal centers; it can upregulate bacterial
ROS scavenging genes (35), modulate protein phosphatase activity (36). H2O2 can function
as more than just a damage signalling molecule which is becoming increasingly
recognized. The most dangerous and harmful ROS species, however, is the hydroxyl
radical (•OH). The formation of the hydroxyl radical can occur in two ways: superoxide
degradation via the iron catalyzed Haber-Weiss reaction, or spontaneous conversion of
H2O2 exposed to UV light (Figure 1.2) (28). It is notable that the second step of the HaberWeiss reaction is the Fenton Reaction, which involves the oxidation of a ferrous ion (Fe2+)
to a ferric ion (Fe3+), and in the process decomposing a hydrogen peroxide molecule into a
hydroxyl radical and a hydroxide ion (29).
First step

Fe3+ + •O2− → Fe2+ + O2

Fenton Reaction (2nd Step)

Fe2+ + H2O2 → Fe3+ + OH− + •OH

Haber Weiss Net Reaction

•O2− + H2O2 → •OH + OH− + O2

Figure 1.2. Haber Weiss net reaction and reaction steps.
The Haber Weiss reaction is a two-step reaction that converts superoxide to a hydroxyl
radical. The second step of the Haber Weiss reaction is additionally known as the Fenton
reaction, which can occur independently and convert hydrogen peroxide to a hydroxyl
radical.
While most ROS are capable of reacting with biological molecules to some degree,
the hydroxyl radical is capable of reacting with virtually all types of biological molecules
and some inorganic molecules as well. The hydroxyl ion has an enormous oxidizing
potential and a half-life of 10-9 seconds, making it an extremely harmful species in vivo
(37). The hydroxyl radical is capable of modifying components of DNA such as the
deoxyribose sugar backbone, purine and pyrimidine bases, and induce single and double
stranded breaks. As ROS concentrations are typically higher in the mitochondria in
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comparison to the nucleus, mitochondrial DNA (mtDNA) has been shown to exhibit higher
levels of oxidative damage. Indeed, the hydroxyl radical has been shown to create adducts
or crosslinks on every DNA/RNA base pair (38), for example, levels of 8-hydroxy
deoxyguanosine (8-OHdG), which is considered as the biomarker of oxidative DNA
damage, is markedly higher in mtDNA as opposed to nuclear DNA, and has been shown
to be implicated in mutagenesis, carcinogenesis and ageing (39). The hydroxyl radical is
also capable of oxidizing lipids, especially polyunsaturated fatty acid residues of
phospholipids. Lipid oxidation has been shown to hamper membrane function causing
decreased fluidity, inactivation of membrane bound enzymes and receptors (40).
Proteins and other amino acid based molecules have been shown to be chemically
modified by superoxide, hydroxyl radical and hydrogen peroxide, among many other
ROS/RNS species (41). ROS are capable of oxidizing residues such as tryptophan,
phenylalanine, tyrosine, histidine, asparagine, aspartic acid, lysine, proline, threonine,
leucine and valine (42), resulting in the denaturation and loss of functioning of proteins,
abolishing enzymatic, transport and receptor activities. The sulfur containing amino acids,
methionine and cysteine, are particularly susceptible to oxidation by ROS and are
converted to methionine sulfoxide and disulfide linkages, respectively. (43, 44). However,
these residues are also readily converted back to their native forms by methionine sulfoxide
reductases and disulfide reductases, respectively (45). Cysteine is particularly capable of
being extensively oxidized to a variety of forms, include disulfides, sulfinic, sulfenic and
sulfonic acids. However, only the native sulfhydryl, the disulfide and sulfenic acid forms
are readily interconverted; oxidation beyond this level is not reversible (Figure 1.3) (45).
The mechanism of oxidation is initiated by the deprotonation of the reacting thiol group,
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and the formation of the thiolate ion. As the pKa of cysteine, 8.5, is well above cellular pH
levels, only a small proportion is cysteine residues would be in the thiolate form at any one
time. The thiolate ion is capable of the nucleophilic attack on an oxygen atom of hydrogen
peroxide, and thus eliminated a hydroxide ion as a leaving group. This sulfenic acid is
similarly subject to nucleophilic attack by another thiolate ion, again eliminating a
hydroxide ion and forming a disulfide As ROS chemical modifications are quite extensive
and affect almost all relevant biological molecules, it is expected that they are ubiquitous
in the development of a wide array of disease. Increased ROS and oxidized product levels
have been implicated in several types of cancer, cardiovascular disease (CVD) (46) and
atherosclerosis (47). ROS-mediated damage is especially prevalent in neurodegenerative
diseases, as the CNS contains high lipid content and a higher metabolic rate due to a high
density of mitochondria.
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Figure 1.3. Oxidation schematics of cysteine oxidation.
Cysteine is readily converted between the sulfhydryl, disulfide and sulfenic acid forms. Increasing levels
of oxidation can convert cysteine to the sulfinic and sulfonic acid forms (A). Reaction mechanism showing
the interconversion between sulfhydryl, sulfenic and disulfide forms (B)

Oxidative stress has a complex role in the development of PD as cascading, selfpropagating mechanism, which in turn may be insightful to the progressive nature of the
disease. Oxidative modifications of SNCA has been shown to promote tyrosine crosslinking, which in turn causes toxic soluble oligomers that may be precursors to LB’s (48).
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As PD is intrinsically tied to the degradation of dopaminergic neurons, dopamine itself
becomes a reactive oxygen species. Indeed, as onset of PD begins with neuronal
deterioration, levels of monoamine oxidase B (MAOB) begin to increase. MAOB
metabolises dopamine into H2O2, which is highly membrane permeable, where it can
diffuse to neighboring dopaminergic neurons and undergo the Fenton reaction to form
hydroxyl radicals, thus propagating ROS mediated damage and further amplifying it (49).

1.4 Parkin
Ubiquitination is a complex signaling pathway where linkage types and substrates can lead
to a variety of molecular fates. The ubiquitination pathway is mediated by an enzymatic
cascade consisting of an E1 activating enzyme, E2 conjugating enzyme and finally an E3
ubiquitin-ligating enzyme, which will catalyze the transfer of ubiquitin to the final
substrate. Parkin preferentially ubiquitinates mitochondrial membrane proteins when
mitochondria become depolarized—a signal of mitochondrial damage.
Parkin belongs to the RING-BetweenRING-RING (RBR) subclass of E3 ubiquitin
ligases. RBR ligases are distinct from other simpler E3 ligases as they display a higher
level of structural complexity, as all RBR’s can be characterized as multidomain proteins
(Figure 1.4). Parkin itself consists of five domains: an N-terminal ubiquitin-like (Ubl)
domain, a RING0 domain, a RING1, a BRcat (benign-required for catalysis) domain and
Rcat (required for catalysis) domain, with the latter three domains comprising the hallmark
RBR sequence (50). RING domains typically have a distinct structural arrangement, where
2 Zn2+ ions are coordinated in a cross-brace fashion (51). While the BRcat and Rcat were
previously assumed to be canonical RING domains, more recent research has deemed them
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as non-canonical RING domains, necessitating the need for contemporary nomenclature
used in this work. RING0, RING1, BRcat and Rcat have a structural commonality in their
Zn2+ coordinating abilities; using a combination cysteine and histidine residues, each
domain coordinates two Zn2+, for a total of eight (52). However, RING1 is the only true
RING domain; RING0 binds two Zn2+ ions in a hairpin arrangement unique to parkin,
while the BRcat and Rcat domains show a sequential arrangement of Zn2+ -coordinating
residues (53). Parkin also contains an impressive proportion of cysteine residues, totalling
35 cysteines which make up 7.5% of the entire protein, in comparison to the human
proteome average of 2.3% (54).The Ubl domain is shared with only one other RBR E3,
heme-oxidized IRP2 ubiquitin ligase-1 (HOIL-1), however its function as an
intramolecular inhibition module is unique to parkin (55). The Ubl domain binds the
RING1 domain to negatively regulate parkin ubiquitination activity, by obstructing the site
required for E2 recruitment and preventing the transfer of ubiquitin (56, 57). The Ubl is
sequentially tethered to RING0 by an extensive linker (residues 77-140) of unknown
function. Deletion of the Ubl and incremental N-terminal deletion of the linker causes
upregulation of parkin activity, however, complete elimination of the Ubl domain and
linker abolishes parkin activity (58).

15

Figure 1.4 Parkin structures and domain map.
Parkin crystal structure from PDB code: 5C1Z. Parkin domains colored and labelled (A). Parkin’s
cysteines are highlighted in red (B) and coordinated zinc ions are indicated by grey spheres. Parkin domain
map (C) showing all cysteine residues in parkin. Cysteines mutated in PD are indicated by an asterisk (*)
and the catalytic cysteine is indicated by two asterisks (**). Pathologic mutations were taken from Uniprot
code O60260.
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In healthy cells, parkin exists in its native, inactive state and is autoinhibited by the
N-terminal Ubl domain. Parkin activation involves dual phosphorylation events by PINK1:
phosphorylation of parkin on Ser-65 in addition to phosphorylation and subsequent binding
of Ser-65 phosphorylated ubiquitin (pUb). Both events are required to facilitate the release
of the autoinhibitory Ubl domain and fully activate parkin. However, PINK1 is
constitutively expressed and then degraded by presenilin associated, rhomboid-like
(PARL) protease (59). As a result of mitochondrial damage, there is a decrease in the
mitochondrial membrane potential, otherwise known as mitochondrial depolarization, at
which point ATP synthesis can no longer occur and mitophagy signaling is initiated (60).
As Figure 1.5 demonstrates, mitochondrial depolarization leads to the inactivation of
PARL, which thus allows the retrograde translocation and stabilization of PINK1 in the
OMM, occurring concurrently with the increase in ROS levels. (61, 62). This allows
PINK1 to phosphorylate OMM proteins that have been previously ubiquitinated, such as
mitofusin and mitoNEET (63); these pUb-attached mitochondrial membrane proteins are
believed to facilitate the selective recruitment of parkin to the periphery of the
mitochondria, while binding of pUb, coupled with PINK1 phosphorylation stimulates
parkin activity.
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Figure 1.5 Overview of PINK1/Parkin mediated mitophagy.
In healthy mitochondria, PARL constitutively cleaves PINK1, thus supressing it (left). When mitochondria
are damaged, PARL is inhibited, allowing for the stabilization of PINK1, which can phosphorylate Parkin
and ubiquitin, initiating and amplifying the signalling pathway for mitophagy.

Previous studies have analyzed parkin in the context of oxidative stress. As parkin
has been found to be upregulated in an in vitro cell based PD model after MPTP-induced
oxidative stress and also showed extensive cysteine modifications (64). Interestingly,
another group demonstrated the formation of parkin dimers as a result of oxidation that
were reversible under reducing conditions, suggesting the possibility of intermolecular
disulfide linkage formation. This group also posited that parkin has potential as a ROS
scavenger when compared maltose binding protein and SNCA (65, 66). Overall, the
evidence shows that parkin may possibly be an oxidation-tolerant molecule and is capable
of fulfilling a secondary function as a ROS scavenger after extensive exposure to oxidizing
conditions.
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1.5 Scope of Thesis
Today we realize that PD is a complex and progressive disorder with an array of genetic or
environmental causes that begin long before the disease is able to be clinically diagnosed.
Current literature has extensively linked the role of mitochondrial dysfunction to the onset
of PD. Parkin is an E3 ubiquitin ligase that belongs to a class of RBR ligases that are
structurally defined by 3 RING-like Zn2+-binding motifs. Parkin is able to coordinate a
total of eight Zn2+ ions via cysteine and histidine coordination. Indeed, parkin contains a
total of 35 cysteine residues, 30 of which participate in Zn2+ coordination, and are essential
for the structure and function. The function of parkin involves the ubiquitination of
mitochondrial membrane protein to initiate the signalling of mitochondrial degradation,
and the loss of this function has been shown to be implicated in the onset of recessive PD.
As mitochondrial dysfunction is a signal for parkin recruitment and activation, which is
concurrent with oxidative stress and an increase of ROS levels, parkin exposure to
oxidative modification is inevitable, and its high proportion of oxidation-prone cysteine
residues could indicate a valuable interaction in the pathogenesis of PD.
Exposure of parkin to oxidation has only been examined at superficially as of recent.
While studies thus far established a correlation in oxidative stress upregulating parkin
activity, only a few studies have analyzed the direct impact of oxidative modifications on
the function of parkin. One study of oxidative stress in the context of parkin, exposed
parkin-overexpressing SH-SY5Ycells to H2O2 and observed an increase in ubiquitination
activity after 2 hours, followed by a decrease in activity after 6 hours (64). The study
rationalized this effect as immediate activation of the parkin pathway however, oxidative
modifications abolished protein function. They also identified the peptides harboring
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oxidative modification, identifying oxidation throughout the entire RBR domain, which is
consistent with cysteine modifications, such as Cys431Phe and Cys441Arg, which are
shown to be genetic mutations responsible for PD development.
In this study, I establish a comprehensive analysis of parkin behaviour as a result of
oxidative stress. The structural alterations of parkin are analyzed using SDS-PAGE and
SDD-AGE in order to observe whether oxidation can influence parkin’s migration rates on
gel-based assays. We also look to identify the possible products of oxidation with special
focus on cysteine thiochemistry, which is capable of forming a multitude of products
depending on the severity of oxidation. Mass spectrometry was used to identify which
cysteine residues are more susceptible to protein oxidation, and to see if they are consistent
with PD related gene mutations or are essential for protein function. We also examine the
possibility of a novel function of parkin as a redox molecule. By conducting a parkin
activity assay under oxidizing conditions, we hope to demonstrate oxidation-mediated
abolishment of function. We will also examine the efficacy of parkin as a ROS scavenger
by measuring its clearance rates of H2O2. As Parkin also uniquely coordinates a large
number of Zn2+ ions, it is also possible that upon oxidation, parkin loses its ability to retain
its Zn2+, which can cause liberation of these ions and possible downstream Zn2+ signalling.
The importance of our study is to examine possible novel functions of parkin. Due
to parkin’s unique structural motifs, as well as the inevitable interaction between parkin
and ROS produced in cells, it could well-suited to act as a redox molecule. Structural
biochemical techniques were used to elucidate the consequences of protein oxidation,
which may further allude to the activation of parkin or inactivation other proteins leading
to the pathogenesis of PD. While the activity of parkin will be assayed under oxidizing
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conditions, we hope to elucidate a novel mechanism parkin. The recruitment of parkin to
the mitochondrial periphery combined with an elevated cysteine content make it an ideal
ROS scavenger, and the likely subsequent loss of Zn2+ ions may act as a potential signalling
pathway.
The field of PD research has cemented the role of parkin as an E3 ubiquitin ligase
that functions in mitochondrial maintenance in the central nervous system. However, the
implication of a novel function will require considerable evidence in order to convince
researchers within the field to accept such a fact. Overall, the analysis of the complex
interplay of oxidative stress and parkin may exemplify an unexplored avenue of parkin
research that may prove valuable in understand the development and pathogenesis of
Parkinson’s Disease. We hope to open new doors with our research, uncovering a facet of
PD research that can have widespread and impactful effect on parkin research.
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Chapter 2

2

Oxidation of Parkin

2.1 Introduction
As this study focuses on parkin’s structure and activity under oxidative stress, we prepared
several different forms of parkin that would allow us to capture the different states of parkin
activation that would be present in cells. Parkin’s function plays a role in mitochondrial
maintenance and upkeep of cellular health. As an E3 ubiquitin ligase that specifically tags
mitochondrial proteins, parkin initiates mitophagy on depolarized mitochondria, which
signals mitochondrial damage (1). Parkin activation involves the action of the upstream
PINK1, which is a protein kinase that is constitutively expressed in the outer mitochondrial
membrane (OMM), however it is rapidly and constitutively degraded when the
mitochondrion is healthy, and its membrane potential is maintained. PINK1 specifically
phosphorylates Ser65 of parkin, as well as the analogous Ser65 of a ubiquitin molecule
(pUb). Parkin phosphorylation and binding with pUb is required for the release of Ubl
domain and full activation (2) the. We took advantage of a Pediculus humanus orthologue
of PINK1 to prepare in vitro phosphorylated parkin and ubiquitin, which has been shown
to retain specificity and is constitutively active as opposed to the natural repressed human
PINK1 (3).
Upon further scrutiny of parkin’s structure and function, several features stand out
that may be suggestive of a novel protein function. As parkin is capable of coordinating
eight Zn2+ ions, which are facilitated by the action of cysteine and histidine residues, a
comparison of cysteine content reveals a massive disparity. Parkin contains an impressive
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35 cysteine residues, which make up 7.5% of the entire protein, in comparison to the human
proteomic average of 2.3% (4). Cysteine, along with methionine, are the only two sulfur
containing residues, while cysteine has a much more reactive thiol group. The thiol group
is especially prone to oxidation, and is capable of forming disulfide links. As recruitment
of parkin to the periphery of dysfunctional mitochondria is an essential step in parkin
activation, this increase the risk of exposure to reactive oxygen species, and thus oxidation.
Previous research has revealed parkin exposure to oxidizing agents is capable forming a
dimer and is able to acts as a potential redox molecule (5). Although parkin’s function has
been well-established as an initiation signal for mitophagy (6), the localization of parkin
combined with its high cysteine content leaves may make parkin well suited as a redox
molecule. Therefore, our study aims to assess parkin’s behaviour at various levels of
oxidation, and provide an extensive analysis and identify the products of oxidation.
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2.2 Materials and Methods
2.2.1 His6-SMT3/His-TEV Tagged proteins
The human PARK2 gene was inserted into a pET-SUMO expression system vector
(Invitrogen) containing an upstream His6-SMT3 affinity tag and transformed into an
Escherichia coli BL21 (DE3) previously by our collaborator at the Walden Lab (University
of Dundee). A parkin truncation (residues 141-465, 141C) was generated using the
Phusion® Mutagenesis Kit (Finnzymes) as previously described (6). The RING2 domain
of Drosophila melanogaster parkin (residues 415C, Rcat) was also inserted into a pETSUMO vector as described above. All constructs were grown at 37 °C in Luria Broth (LB)
media (Fisher BioReagents) and were supplemented with 250 µM ZnCl2 at inoculation and
at induction. Cells were induced at an optical density at 600 nm (OD600) of 0.6 with 25
µM of isopropyl β-D-1-thiogalactopyranoside (IPTG) for full-length parkin, 0.1 mM for
141C or 0.5 mM for Rcat, then cells were incubated overnight at 16 °C. Cells were
harvested in T500 lysis buffer (50 mM Tris, 500 mM NaCl, 0.5 mM TCEP, 25 mM
imidazole, pH 8.0) and lysed with an Avestin EmulsiFlex-C5 homogenizer (ATA
Scientific) at 15,000 psi. Cell lysates were ultra-centrifuged at 41,000 rpm (124,000 x g)
and the pelleted cellular debris was discarded. Proteins were purified by Ni2+ affinity using
a HisTrap FF column on an AKTA FPLC (GE Healthcare). Proteins were bound and
extensively washed with lysis buffer, then eluted with T200e elution buffer (50 mM
tris(hydroxymethyl)aminomethane (Tris), 200 mM NaCl, 0.5 mM TCEP, 250 mM
imidazole, pH 8.0). Proteins were concurrently incubated with 2.5 mg of His-Ulp1 per liter
of growth and dialyzed into T200 wash buffer (50 mM Tris, 200 mM NaCl, 0.5 mM TCEP,
pH 8.0). The cleavage product was then run through a second His-Trap FF column to
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remove His6-Ulp1 and cleaved His6-SMT3, and the cleaved protein was collected in the
flow-through. Purified protein samples were concentrated using Vivaspin protein
concentrator spin columns (GE Healthcare) and were further purified using SuperDex75
10/300 GL size exclusion columns (GE Healthcare). Sacchromyces cerevisiae ubiquitin
was expressed as a His6-TEV fusion construct and purified in a similar manner to the His6SMT3 fusion proteins but the affinity tag was cleaved by tobacco etch virus protease
(TEV). Protein concentrations were measured by absorbance at 280 nm with a DeNovix
DS-11 FX+ Spectrophotometer.

2.2.2 GST-PINK1
Pediculus humanus PINK1 (128-C) construct was cloned into a pGEX-6P1 GST Fusion
vector, transformed into BL21 (DE3) Codon+ RIL cell line by, and was obtained from, Dr.
Helen Walden (University of Glasgow). Cells were grown in LB media at 37°C to an
OD600 of 0.8. Cells were induced with the addition of 0.1 mM IPTG, then incubated
overnight at 26°C. Cells were harvested and resuspended in PBS buffer (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Cell suspensions were lysed as
described above and the supernatant was purified using a GSTrap FF column (GE
Healthcare), washing extensively with lysis buffer and eluted with freshly prepared PBS
plus 10 mM reduced glutathione. Purified GST-PINK1 was extensively dialyzed against
two changes of T200 buffer pH 10.0 to remove the bound glutathione, and then against
T200 pH 8.0.
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2.2.3 Preparation of Phosphorylated Parkin and Ubiquitin
Purified GST-PINK1 was incubated with either full length parkin (1:2 ratio) or ubiquitin
(1:10 ratio) and dialyzed against buffer containing 50 mM Tris, 1.0 mM DTT, 10 mM
MgCl2 and 10 mM ATP (pH 7.5) at 25°C overnight. Protein phosphorylation was
monitored to completion using a phosphorylation affinity reagent, Phos-Tag AAL™
(NARD Institute Ltd) SDS–PAGE. Phosphorylated species have their migration rates
retarded by the Phos-tag reagent, manifesting as an upshifted band on SDS-PAGE.
Following the reaction, GST-PINK1 was removed using a GSTrap FF column, collecting
the flow-through fractions containing phosphorylated parkin or phosphorylated Ub. The
phosphorylated proteins were further enriched using a SuperDex75 10/300 GL column (GE
Healthcare) size exclusion chromatography.

2.2.4 Oxidation
Purified protein samples were reacted in buffer containing 50 mM HEPES, 50 mM NaCl
pH 7.0. Protein samples were prepared at 15 µM (141C, parkin, phospho-parkin) or 30 µM
(RCat) and were exposed to various concentrations of hydrogen peroxide (Sigma Aldrich)
over the course of 1 or 2 hours. Reactions containing pUb were conducted using a 1:1 ratio
of pUb:parkin construct. Samples were taken at selected time points, quenched with 5 mM
ascorbic acid and sample buffer, then incubated at room temperature for 1 hour. Samples
were loaded onto a 15% SDS-PAGE gel and stained with Coomassie Brilliant Blue R-250
(Thermo Fisher Scientific). Gels were destained then imaged using a BioRad Gel Doc
Imaging system.
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2.2.5 Analysis of protein aggregates
Protein samples were oxidized in a time course as described above. The semi denaturing
detergent agarose gel electrophoresis (SDD-AGE) protocol was conducted as previously
described with minor modifications (8). The agarose-based gel was used to due to its larger
pore size which allows analysis of structurally heterogenous amyloidogenic proteins whose
insolubility and size are difficult to analyze using conventional SDS-PAGE. Samples were
then loaded onto a 1.8% agarose gel containing 1% SDS with running buffer containing 40
mM Tris acetate, 10 mM ethylenediaminetetraacetic acid (EDTA) and 1% SDS. SDSsoluble proteins from the agarose gel were then transferred to a PVDF membrane overnight
using a Whatman TurboBlotter kit using Tris Buffered Saline (TBS; 10 mM Tris, 150 mM
NaCl pH 7.0). Membranes were blocked with 5% skim milk powder in PBST (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 0.1% Tween, pH 7.4) for 1 hour
with shaking then probed with a 1:10000 dilution parkin RING2 mouse antibodies (Cell
Signalling) at 4°C on a rocker overnight. Membranes were then probed with Alexa 680
labelled anti-mouse secondary antibodies at room temperature for one hour, then rinsed
with PBST and visualized on a LiCor Odyssey imaging system.

2.2.6 Identification of oxidized species
Samples (parkin, phosphoparkin, 141C and Rcat) were oxidized at 1 mM H2O2 for 3 or 15
minutes then quenched with ascorbic acid. Samples were then desalted using 500 µL Zeba
Spin Desalting Column (Thermo Fisher Scientific) according to manufacturer’s protocol.
Mass spectrometry was performed on a QTof Ulitma mass spectrometer (Waters) equipped
with a Z-spray source and run in positive ion mode with an Agilent 1100 HPLC used for
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flow injection. MassLynx 4.1 software was used for data acquisition and data were
deconvoluted using MaxEnt1.

2.2.7 Band densitometry and reaction modeling
141C parkin was used as representative protein. Time course oxidation assays of 15 µΜ
141C were conducted in 1, 5 and 10 mM H2O2 in the presence and absence of pUb and
were analyzed with SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R250
band intensity of oxidized species over time. SDS imaged using BioRad Gel Doc and band
intensity was measured using ImageLab software. Band intensities were normalized to the
highest intensity protein band present on the gel and data were analyzed using Prism
software.

2.3 Results
2.3.1 Purification of parkin proteins
For the experiments outlined in this study, recombinant parkin had to be expressed and
modified to mimic the different states associated with parkin activity: full-length human
parkin (1-465), an N-terminally truncated form, 141C (141-465), and D. melanogaster
RCat, as previously described and displayed in Figure 1.4C. As previously shown (9),
untagged parkin expressed poorly and was highly insoluble, while His- or GST tagged
parkin yielded a purified protein product that showed degradation and was of poor quality.
Parkin expression benefitted greatly from the addition of the His-SMT3 affinity tag and
remained soluble even after cleavage (7). All proteins were soluble in LB media
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supplemented with 0.5 mM ZnCl2, and protein expression was induced only after cells had
been cooled to 16°C (Figure 2.1). Full-length His-SMT3 parkin was purified using a Ni2+
NTA affinity column, however the first elution was very impure, showing multiple bands
from 11 kDa and well beyond the limits of the molecular weight ladder. This protein
mixture after cleavage with Ulp1 showed some uncleaved protein, however the majority
of the protein was able to be cleaved (Figure 2.1A). The protein mixture showed several
contaminants that were retained after a second Ni2+ NTA affinity column, yielding purified
full-length parkin band that ran at the expected 52 kDa, with some light contamination with
lower molecular weight species in the 11-17 kDa range (Fig 2.1A). 141C and Rcat were
purified in a similar manner, however both proteins had markedly less contamination in
their initial elutions. Both proteins showed a larger proportion of Ulp1 cleavage (Figure
2.1B-C).
After a second Ni2+ NTA affinity column, both proteins were comparatively pure, with
very minor contamination in either case. All the above constructs were purified to
homogeneity using size exclusion chromatography as a final purification step prior to all
experiments.
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Figure 2.1. Purification of His6-tagged Parkin and ubiquitin constructs.
SDS-PAGE gels showing purifications of His6-tagged recombinant proteins used in this study. Parkin (A),
141C (B) and Rcat (C) were expressed as His6-SMT3 constructs, while ubiquitin (D) was expressed as a
His6-TEV construct. Flowthrough 2 indicated the final protein product to be used in further experiments, or
were subject to size exclusion chromatography for further purification.
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2.3.2 Purification of GST-PINK1
PINK1 is a kinase for both parkin and ubiquitin and plays an essential role in parkin
activation in cells (Figure 2.2). P. humanus PINK1 has been shown to reliably
phosphorylate parkin and ubiquitin and is essential for in vitro preparation of different
forms of parkin. PINK1 remained soluble in LB media growth and induction at 26 °C. Cell
pellets were suspended and lysed in PBS buffer and PINK1 was purified using a GSTTrap. PINK1 was eluted using reduced glutathione, giving rise to a band at 75 kDa,
however the sample had several other contaminants. PINK1 remains in solution despite
extensive dialysis at pH 10, which is required to remove reduced glutathione, as well as
into a Tris buffer at pH 8.0.

2.3.3 PINK1 reliably phosphorylates parkin and ubiquitin
An essential step in parkin activation involves two phosphorylation events:
phosphorylation of parkin’s Ubl domain on S65 and the phosphorylation of ubiquitin on it
analogous S65. However, human PINK1 is sub optimal in terms of kinase activity and is
unreliable for preparative phosphorylation of parkin of PINK1. We instead used an insect
orthologue, specifically P. humanus PINK1, that is constitutively active and provides a
reliable method of parkin and ubiquitin phosphorylation (2, 3). Recombinant PINK1 was
successfully expressed as a GST-fusion protein lacking the N-terminal mitochondrial
targeting and transmembrane domains. Purified PINK1 was used to successfully
phosphorylate both parkin and ubiquitin, which were monitored using Phos-Tag SDSPAGE (10, 11). Both parkin and ubiquitin exhibited complete phosphorylation (Figure
2.2) as indicated by depletion of the faster migrating band of the unphosphorylated species
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and subsequent formation of the impeded, phosphorylated species. Phosphorylated parkin
(phospho-parkin) was further enriched using GST affinity chromatography to remove
PINK1 and size exclusion chromatography to remove residual ATP. Phosphorylated
ubiquitin (pUb) was also similarly enriched, however, GST affinity chromatography could
be omitted as size exclusion chromatography was sufficient to resolve the substantial size
difference between PINK1 and pUb.
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Figure 2.2. PINK1 Purification and in vitro phosphorylation of parkin and ubiquitin.
SDS-PAGE gels showing purifications of GST-tagged recombinant PINK1 (A). Ubiquitin (B) and parkin
(C) in vitro phosphorylation by PINK1, then analyzed using SDS-PAGE with Phos-Tag AAL reagent. The
presence of phosphate on ubiquitin and parkin retards migration rates by interacting with the Phos-Tag
reagent.
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2.3.4 Parkin oxidation forms multiple discrete species
In order to identify how oxidation might alter the structure of parkin we exposed parkin to
a broad range of hydrogen peroxide (H2O2) concentrations (0-10 mM) and monitored
reactions over a 2-hour time period. We expect some obvious structural modifications to
occur due to parkin containing such a high cysteine content combined with exposure to an
oxidizing environment, which may be readily visualized by SDS-PAGE. After exposure to
H2O2, residual H2O2 was quenched using ascorbic acid, rather than DTT or TCEP, which
is able to reduce H2O2 while remaining non-reactive to the oxidized protein. The ascorbic
acid was thus used to halt the oxidation process while preserving any oxidized states of
parkin.

2.3.4.1

Oxidation: Parkin

In the absence of hydrogen peroxide, parkin runs at its expected 52 kDa size on nonreducing SDS PAGE gels, which remains consistent at 37 °C (Figure 2.3A). Upon
oxidation, a number of new bands appear that are dependent on the H2O2 concentration and
reaction time. At the lowest H2O2 concentration tested (1 mM) parkin rapidly forms a lower
molecular weight species that runs as a broader band of approximately 48 kDa on the gel,
while in later timepoints a larger species of approximately 80 kDa starts to form, as well
as some slightly larger molecular weight species begin to form (Figure 2.3A). At higher
H2O2 concentrations (5 and 10 mM) this oxidation process is accelerated, revealing the
transition of the dimeric species to even larger oligomers, as evidenced by a laddering
pattern which spans all the way up to the well. These oligomers have some degree of
solubility but eventually become too large to enter or migrate any discernable distance into
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the gel. This process of oligomerization is occurring more quickly in higher concentrations
of H2O2, which is suggestive of disulfide mediated intermolecular linkages as the
mechanism of oligomer formation. The addition of TCEP after the reaction is able to
recover parkin back to its un oxidized monomeric state, as evidenced by the band that runs
similarly at 52 kDa.

2.3.4.2

Oxidation of 141C

Compared to parkin, the N-terminally truncated form 141C oxidized in a similar manner,
initially forming a broader, faster migrating band at approximately 30 kDa. This species is
eventually depleted as oxidation creates a ladder of higher molecular weight species.
However, 141C and parkin differ in their rates of oxidation; while parkin maintains a strong
monomeric band that can be observed throughout the entire reaction at 1 mM H2O2, 141C
is almost completely absent by the 120-minute mark. These trends are similar across H2O2
concentrations, 141C is only faintly observed at 10 and 5 minutes for 5 and 10 mM H2O2,
respectively, while is maintained to a similar intensity at the 30- and 10-minute time points.
Both the full length and truncated forms of parkin eventually proceed to insolubility with
no detectable protein at that point.

2.3.4.3

Oxidation Assay: Phosphorylation and addition of pUb

As parkin, phosphoparkin and 141C have the capacity to bind pUb, all three
proteins were oxidized in the presence of pUb in a 1:1 ratio (Figure 2.5, 2.6). In the
presence of pUb, both parkin and phosphoparkin can be observed oxidizing at a slightly
slower rate when exposed to 1 mM H2O2, as observed by the higher band intensity at 120
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minutes, compared to when pUb is absent (Figure 2.6). Similarly, 141C oxidation is
delayed in the presence of pUb at all levels of oxidation, with protein being comparably
more observed at 90, 15, and 10 minutes at 1, 5 and 10 mM H2O2, respectively (Figure
2.5). When comparing parkin and phosphoparkin oxidation rates in 1 mM H2O2, very little
change occurs with the addition of phosphorylation. Both proteins exhibit similar rates of
oligomerization, however, it is interesting that upon reduction with TCEP, phosphoparkin
is able to be recovered to a higher degree as evidenced by the higher intensity of the
monomeric band at 52 kDa after TCEP treatment.

2.3.4.4

Oxidation of Rcat

Rcat was oxidized in a similar manner to parkin at a wider range of H2O2 concentrations:
0.5, 1, 2, 5, 10 and 20 mM (Figure 2.5). Rcat was more resistant to oxidation, differing
from the more obvious changes that occurred in the full-length parkin at similar H2O2
concentrations. Oxidation assays of Rcat revealed very little change at lower H2O2
concentrations, showing only faint dimer bands until 2 hours at 2 mM H2O2, where higher
molecular weight species can start to be observed. However, due to the smaller molecular
weight of Rcat, oligomerization is much more apparent, and bands are much more
distinguishable up to 6 units long (Figure 2.5).
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Figure 2.3. Parkin oxidation time course assays.
Parkin was oxidized at 0, 1, 5 and 10 mM H2O2 (as indicated) in a 50 mM HEPES, 50 mM NaCl pH 7.0
buffer. Reactions were quenched with 20 mM ascorbic acid to extinguish remaining H2O2. Samples were
run on 16.5% tris-tricine SDS-PAGE, stained with Coomassie Brilliant Blue and imaged using a BIORAD
Gel Doc.
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Figure 2.4. Rcat oxidation time course assays.
Rcat was oxidized at 0.5 (A), 1 (B), 2 (C), 5 (D), 10 (E) and 20 (F) mM H2O2 in a 50 mM HEPES, 50 mM
NaCl pH 7.0 buffer. Reactions were quenched with 20 mM ascorbic acid to deplete any remaining H2O2.
Samples were run on 16.5% tris-tricine SDS-PAGE and stained with Coomassie Brilliant Blue and imaged
using a BIORAD Gel Doc.
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Figure 2.5. 141C oxidation time course assays with and without phosphorylated ubiquitin.
141C was oxidized at 1, 5 and 10 mM (A-C) H2O2, and with phosphorylated ubiquitin in a 1:1 ratio (D-F)
at the same concentrations in a 50 mM HEPES, 50 mM NaCl pH 7.0 buffer. Reactions were quenched
with 20 mM ascorbic acid to deplete any remaining H2O2. Samples were run on 16.5% tris-tricine SDSPAGE and stained with Coomassie Brilliant Blue and imaged using a BIORAD Gel Doc.
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Figure 2.6. Parkin and phosphoparkin oxidation assays
Parkin (A) and phosphoparkin (C) were oxidized at 1mM H2O2 in the absence and in the presence
phosphorylated ubiquitin in a 1:1 ratio (B and D respectively) in a 50 mM HEPES, 50 mM NaCl pH 7.0
buffer. Reactions were quenched with 20 mM ascorbic acid to deplete any remaining H2O2. Samples were
run on 16.5% tris-tricine SDS-PAGE and stained with Coomassie Brilliant Blue and imaged using a
BIORAD Gel Doc.
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2.3.5 Oxidation of parkin results in disulfide bridge formation
While the oxidation assays suggested the presence of higher molecular oligomerization
occurring as a result of oxidation, we used mass spectrometry to identify the products of
the oxidative process. Mass spectrometry analysis of unmodified parkin shows a single
signal at 51640.89 Da, corresponding to the theoretical mass of parkin (51640.893 Da)
(Figure 2.7A). Upon a short period of oxidation, the parent mass of parkin is absent and
replaced by a major signal at 51638.6 Da, and a minor peak at 103277.5 Da (Figure 2.7B).
The major signal is consistent with the loss of two hydrogen atoms arising from the
formation of an intramolecular disulfide linkage in parkin. This causes the protein to
migrate faster on an SDS-PAGE gel, presumably due to its more compact nature. Similar
observations have been made for phosphoparkin, 141C and D. melanogaster Rcat (Figures
not shown). One difference is that lack of a dimeric species when phosphoparkin was
oxidized. The minor signal in the oxidized parkin spectrum arises from loss of four
hydrogens atoms and likely corresponds to a dimeric parkin species formed by at least one
intermolecular disulfide linkage. No higher molecular weight species were identifiable by
mass spectrometry beyond these molecular weight ranges.
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Figure 2.7. Mass spectrometry analysis of parkin before and after oxidation.
Deconvoluted spectra of parkin before exposure to H2O2 and after exposure to 5mM H2O2 for 3 minutes,
then quenched with ascorbic acid. Mass spectral ranges analyzed were inclusive of monomeric and dimeric
masses, as well as larger molecular weight species but no signal was detected.
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2.3.6 Parkin forms large molecular weight polymers analogous to
Huntington’s Disease proteins
A Semi-Denaturing Detergent Agarose Gel Electrophoresis (SDD-AGE) approach was
used to characterize the larger molecular weight species. SDD-AGE is an approach used
for detection of protein polymers and aggregates that are stable in 1% SDS, unlike most
protein complexes. This method has well established for characterizing protein aggregates
well in excess of 1000 kDa that are too large to enter conventional SDS-PAGE.
Specifically, SDD-AGE has previously been used to characterize the hallmark PolyQ
protein aggregates seen in Huntington’s disease. To confirm the presence of larger
molecular weight oligomers, parkin and 141C were oxidized in 1 or 5 mM H2O2 over a 2hour time course. Samples run on SDD-AGE were then transferred to a PVDF membrane
using a downward capillary transfer blotting setup. Proteins were initially probed using
RING2 specific antibodies, then were probed with secondary antibodies tagged with Alexa
680 fluorophore. Analysis of signal intensity revealed a time dependent formation of large
protein aggregates, showing a smear that is darkest at 10 minutes, then appears to lose
intensity by 15 minutes and disappears at the 30-minute mark (Figure 2.8). These samples
were run parallel to two Huntington’s Disease related PolyQ constructs: 25Q, which does
not form any protein aggregates, and 72Q, a known protein aggregate. At time = 0 min,
parkin runs as a monomeric band, however, the band starts to elongate almost immediately
after oxidation. After 10 minutes, parkin achieves a protein smear that mirrors that of 72Q,
but also runs the entire length between monomer and the well, which indicates a
heterogenous mixture of polymer lengths. A similar result was found for 141C as well,
with the exception that 141C oxidized more quickly in the 5 mM H2O2 treatment.
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Figure 2.8. SDD-AGE monitored analysis of oxidized parkin constructs over 2-hour time courses.
SDD-AGE analysis of parkin and 141C were oxidized at 1 and 5 mM H2O2 and time points were quenched
with ascorbic acid. Gels were transferred to PVDF membrane and proteins were probed with RING2
specific antibodies and Alexa 680 tagged secondary antibodies. Controls (top left, side set) include two
Huntington’s disease implicated proteins, 25Q, which has been shown to not aggregate, and 72Q, which
has been shown to aggregate.
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2.3.7 Products of oxidation followed an ordered pathway
To provide more insight into the actual formation of the oxidized species, band
densitometry was used to measure formation of each discrete species. For this experiment,
141C was used in lieu of parkin for band densitometry analysis. Both proteins show a very
similar progression of oxidation, with the added benefit that 141C gels contained fewer
contaminants, simplifying band densitometry measurements. We used the oxidation of
141C at 5 mM H2O2 for our explanation (Figure 2.10B). We separated each lane into
ranges surrounding discrete bands depending on migration distance, in which we measured
Coomassie stain intensity. The largest raw intensity value was assigned a value of 1, and
all other measurements were normalized to this value. Our initial material is presumably
unoxidized monomer, while the downshifted band which forms immediately after adding
H2O2 is presumably oxidized monomeric protein. Above the oxidized monomer is most
likely oxidized dimer and all increasingly larger material was grouped as polymeric
species. Following exposure to oxidation, the unoxidized monomer (red curve)
downshifted immediately, giving rise to the broader, faster migrating band. The oxidized
monomeric species (black curve) had the highest raw signal intensity, and after
normalization, the initial material had an intensity of approximately 0.6. The oxidized
material is most likely a heterogenous mixture of intramolecular disulfide bonds, which
would have slightly different migration rates, causing the much broader band as a result of
oxidation. The unoxidized material an expectedly more homogenous mixture which results
in a thin and sharp band, which is limited in the amount of Coomassie stain uptake and
therefore, results cannot be strictly quantitative. However, as a semi-quantitative method
we still observed the almost instantaneous formation of the oxidized monomer which our
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model shows should peak at a value beyond the limits of our graph, but tapers off
throughout the rest of the reaction. The dimeric species (blue curve) is also shown to
increase almost instantaneously, band densitometry shows a slower formation than the
oxidized monomer. This species peaks at 0.3 at approximately 2 minutes, then tapers off
and disappears. Subsequently, the polymeric species (green curve) have a delayed start of
formation, and begins to increase at approximately 2 minutes, which is concurrent with the
maximal peak intensity of the dimeric species. The polymeric species then peaks at
approximately 3 minutes to a value of 0.7. It is interesting to note that in most conditions,
the monomeric oxidized species persists longer than any of the higher order molecular
weight species. We propose a potential pathway, as shown in Figure 2.9. A possible bottle
neck occurs where the monomeric oxidized exists.

Figure 2.9. Proposed reaction schematic of parkin oxidation.
Parkin (as indicated by P) oxidation proceeds through a possible pathway, where the
unoxidized, monomeric form of parkin is oxidized while remaining monomeric, then
proceeds to form intermolecular disulfide bonds. These bonds forms dimers, then proceed
to polymerize, forming subsequently larger molecular species until it eventually proceeds
to insolubilization.
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Figure 2.10. 141C oxidation time course plots.
ImageJ was used to measure band density and plotted as relative abundance for each condition: 1mM
(A), 5mM (B), and 10mM (C) for 141C alone and with phosphorylated ubiquitin (D,E,F). The species
measured include unoxidized monomer (red), oxidized monomer (black), dimer (blue) and polymer
(green). Data were analyzed using non-linear regression with a modified one phase decay models using
Prism software. Error bars are derived from an n=3.
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2.4 Discussion
The current understanding of parkin’s function is that it plays a neuroprotective role in cells
via its E3 ubiquitin ligase activity. Parkin is recruited to the periphery of dysfunctional
mitochondria and targets them to the proteasome via ubiquitin-mediated degradation.
Considering parkin’s localization and its above average cysteine content, it is not surprising
that parkin is susceptible to oxidative modifications, and indeed has been shown to be
oxidized in vivo. Therefore, we set out to examine parkin’s behavior under oxidizing
conditions.
The collection of proteins that were purified for the purposes of this study
encompass a crucial step in parkin regulation and activation. In cells, parkin activity is
closely linked to mitochondrial health, as depolarization of the mitochondrial membrane
allows PINK1 stabilization on the OMM, where PINK1 can phosphorylate parkin and
ubiquitin. Both events are required for release of the autoinhibitory Ubl domain, allowing
parkin to adopt an extended, active conformation. While the exact mechanism of parkin
recruitment and activation is still yet unknown, we are aware of possible parkin
intermediates before it is fully activated. Unmodified, wild-type parkin is the inactivated
form of parkin, while pUb-bound, phosphorylated parkin is the fully activated form,
however the order of these events remains unclear. I prepared both phosphorylated parkin
and phosphorylated ubiquitin to homogeneity, which allowed me to either recreate parkin
activation in both scenarios, whether pUb binding occurs first or parkin phosphorylation
does. Both parkin and phosphoparkin are capable of binding to pUb with high affinity, as
they both elute in complex with pUb in the same fractions using size exclusion
chromatography as previously shown (12).
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Parkin was also expressed as two truncations, the human 141C and Rcat domain
from D. melanogaster. The 141C, which acts as a pseudo-uninhibited form of parkin,
construct lacks two consecutive domains: the autoinhibitory Ubl domain (1-76) and a
disordered linker of unknown function (77-140). The Rcat domain, while functionally
inoperable when isolated, contains parkin’s catalytic cysteine. Additionally, as a RINGlike domain, it is used as a representative of the full-length protein which contains 4 RINGlike domains that all coordinate 2 Zn2+, and its high solubility and exceptional expression
levels provide a simple model that is easy to work with.
It is important to note that while cellular levels of ROS are maintained between 10
and 100 nM, we tested an array of H2O2 concentration that were much higher (0.5-20 mM)
(Figures 2.3-2.6), because this was a more practical concentration to show parkin’s
behavior as a result of oxidative stress. These results can be interpreted as an accelerated
process that would occur, as opposed to the chronic exposure to low levels of H2O2, and
possibly reflect the symptoms prevalent in PD patients. By initially exposing parkin to
H2O2, we were able to observe an initial downshifting of parkin when analyzed on SDSPAGE (Figure 2.3). This increased migration rate is most likely due to intramolecular
disulfide bridge formation, as identified by mass spectrometry by a mass loss of 2 Da,
which is consistent with the loss of 2 hydrogen atoms (Figure 2.6). The downshifted band
is much broader than the initial protein, which may be an indicator of disulfide bond
heterogeneity. Parkin contains 35 cysteines residues, the majority of which participate in
Zn2+ coordination, thus creating ample opportunities of closely associated cysteines that
can participate in disulfide bond formation. This could give rise to a mixture of compacted
protein molecules with slightly different migration rates. The reaction then proceeds to
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form a larger dimeric species, which was observable by mass spectrometry, but at a very
small intensity (Figure 2.6). Interestingly, the dimer was observable for parkin, 141C and
Rcat, but not phosphoparkin. The degrees of mass losses were slightly varied across each
construct. Parkin formed a dimer that was twice the mass of an unoxidized monomer less
5.31 Da, corresponding to a loss of approximately 6 total hydrogen atoms. This would be
consistent with a total of 2 intramolecular disulfide bonds and one intermolecular disulfide
bond, however any possible arrangement of inter- and intramolecular bond formation could
occur as long as one intermolecular disulfide bond existed. Interestingly, 141C exhibited
much more extensive disulfide bond formation, as the dimer mass detected was 13.71
Daltons lighter than the mass of 2 unoxidized monomers. This would correspond to a
possible 7 total disulfide bonds formed, which may be due to more extensive solvent
exposure as 141C lacks the Ubl domain and linker domains. These domains only contain
only two cysteines but may protect cysteine residues within BRcat and RING1.
Interestingly, oxidized Rcat formed a monomer with a mass loss of 1.14 Da, a dimer with
a total mass loss of 2 Da, which corresponds to a single intermolecular bond. RCat does
not form a dramatically downshifted band similar to full length and 141C parkin, which
may be attributed to its smaller size and therefore migration rate is not dramatically altered
by an intra molecular disulfide, or the RCat does not favorably form intramolecular
disulfide bonds and instead preferentially forms intermolecular linkages instead.
While analysis by mass spectrometry was limited to only detecting dimer formation
as a result of oxidation, the data obtained validated the presence of intra- and intermolecular
disulfide bond formation. However, SDS-PAGE analysis also showed higher order
molecular weight species, and in order to characterize such high molecular weight species,
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we used an SDD-AGE approach. Parkin and 141C exposure to oxidation formed polymers
much more extensively than what could possibly be observed on SDS-PAGE. This process
is accelerated as a result of higher H2O2 concentration, which is consistent with our finding
from SDS-PAGE. As SDD-AGE is not a quantitative method, our loading controls
included two Huntington’s disease-related PolyQ proteins. These proteins 25Q and 72Q
are model poly-glutamine repeats, where 25Q is a benign poly-Q repeat that is not shown
to aggregate, while 72Q is a pathologically toxic poly-Q length and is shown to be highly
prone to aggregation and subsequent formation of inclusion bodies. Prior to oxidation,
parkin runs as a distinctly monomeric species similar to 25Q, however upon exposure to
H2O2, the parkin band begins to elongate, stretching the entire span from monomeric
weight to the well after 2 hours exposure to 1 mM H2O2 (Figure 2.7). This process is
accelerated in 5 mM H2O2, which is consistent with our previous analysis of these oxidation
products with SDS-PAGE. Parkin runs as a smear that does not parallel completely with
72Q; 72Q resides in the upper half of the gel length, which may indicate a heterogenous
mixture of parkin-polymer lengths as a result of oxidation. Oxidation eventually causes the
parkin to become insoluble and resistant to solubilization in 1% SDS conditions, an
observation that could be a contributing factor to protein aggregation leading to LB
formation. Parkin has been found in LB in PD patients that present with the protein
aggregates (13), and these findings suggest oxidative stress may be a driving factor for LB
formation in PD patients.
Oxidation of parkin and its constructs gave rise to multiple species, so we looked
to examine a possible oxidative pathway that the reaction proceeds along. By using band
densitometry analysis, we were able to plot band intensities and monitor their changes as
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oxidation occurred. In our analyses, having minimal background was absolutely crucial,
therefore 141C gels were chosen for quantification, as full-length parkin had a larger
molecular weight contaminant at time = 0 min, and 141C is more similar to the full-length
parkin than Rcat is. We observed the formation of four distinct species on SDS-PAGE,
unoxidized monomer, oxidized monomer, oxidized dimer, and any larger species were
grouped as a polymer. Immediately after exposure to H2O2, the 141C formed a broader,
faster migrating band, which is accompanied with an expected immediate loss of the initial
unoxidized monomer (Figure 2.8). We assume that an intramolecular disulfide bond alters
the conformation of 141C, making it more compact and thus migrating through the
acrylamide gel slightly quicker. Our band densitometry analysis, however, measured a
higher band intensity for the first oxidized time point than the initial, unoxidized protein
by a factor of 1.5. As the unoxidized monomer band is a very narrow, compact band, it
could be limited by the amount of stain uptake. Band densitometry of Coomassie stained
proteins is inherently flawed, and results can be confounded by factors such as variations
in dye binding between oxidized and unoxidized proteins, inaccuracy in integrating small
areas during data analysis, and amount of dye compared to protein present is not an exact
proportion (13).
Therefore, band densitometry analysis should be interpreted with caution, and any
analysis completed is not quantitative and should be look at for trends only. However, when
comparing the same species over time, I was able to track the oxidized monomer, and in
lower levels of oxidation it seemingly persists in a high proportion throughout the reaction,
remaining in solution longer than the larger species. With very little delay, we see the
formation of the dimeric species which peaks within the first few minutes of the reaction
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in all conditions, occurring after the oxidized monomer. This species peaks at approximate
0.2-0.3 intensity, then immediately begins to taper off as well, most likely as it becomes
insoluble. The next species to form is the polymeric band. As this band was analyzed as a
range between the trimer up to the gel well, it covers a wide range of molecular weight. It
is apparent that these species form after dimer formation has occurred, then also falls out
of solution. The data suggests an ordered, oxidative pathway (Figure 2.9), where oxidation
modifies the initial proteins, which can then form dimers, followed by trimers and so on.
This suggests a time dependent polymerization in an oxidative environment. As the
oxidized monomer persists throughout the entire reaction, it could be indicating that more
extensive polymerization in the form of intermolecular disulfide bonds occurs much more
slowly, while intramolecular bonds form almost instantly. We can also posit that oxidation
decreases the solubility of 141C and eventually causes it to precipitate.
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Chapter 3

3

Consequences and efficacy of Parkin oxidation: an
interplay of cysteine and Zn2+

3.1 Introduction
While our experiments thus far have yielded interesting results into the behaviour of parkin
in an oxidizing environment relevant to the development and pathophysiology of some PD
symptoms, I look to further establish the function and consequences of parkin as a redox
molecule. As oxidation has been shown to chemically alter cysteine residues of parkin, I
looked to explore further consequences of oxidation of cysteine’s thiol group, possibly
effecting both structure and functionality of the enzyme.
Although our mass spectrometry analysis is suggestive of the presence of oxidized
cysteine disulfide linkages, I looked to take advantage of cysteine reactivity to further
analyze oxidative dynamics, specifically the order in which cysteine oxidation occurs.
Cysteine’s role in parkin is indispensable, with the majority of cysteine residues being
responsible for coordinating 8 structural Zn2+ ions (1). One of the remaining cysteines
participates in the catalytic function of parkin, while the remainder are not specifically
assigned a functional role. Previous studies have shown an increase in labelling efficacy of
the catalytic cysteine as an effect of parkin phosphorylation, but not in the case of pUb
bound parkin, suggesting that while the latter does not induce a dramatic conformational
change, full parkin activation plays a role in altering cysteine accessibility (2, 3). One study
employed a mass spectrometry/tryptic digest approach to identify sites of oxidation,
however, the study was limited to only identifying peptides containing oxidation (4). We
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aim to expand on this approach by using a two-step alkylation protocol to elucidate which
cysteines are more vulnerable to oxidation.
The vulnerability of cysteine oxidation is also essential for Zn2+ coordination.
While some cysteines may exhibit varying degrees of solvent accessibility, this may
translate into a possible mechanistically timed release of Zn2+ into the cytosol. Parkin binds
8 Zn2+ ions and each of these Zn2+ binding sites may be distinct species that oxidize in
different timepoints. This is significant, given that Zn2+ ion signalling operates at a
dramatically lower effective concentration, within the range on 10-9 and 10-12 M, in
comparison to Mg2+ and Ca2+, which operate between 10-3-10-6 and 10-6-10-9 M,
respectively (5). If oxidative modifications of parkin facilitated Zn2+ release, this could
allow oxidative stress to propagate a Zn2+-based signalling pathway. These signalling
pathways would thus be a molecular switch that is sensitive to redox levels as cysteine
thiols, which are redox sensitive, commonly coordinate Zn2+. Interestingly, Zn2+ itself is
redox inert (5). Indeed, data has shown that some proteins have shown Zn2+-binding
inhibition sites such as receptor protein tyrosine phosphatase β (6).
Concurrent with parkin’s ability to release Zn2+ is its obvious oxidation as a result of
H2O2. However, parkin contains an extremely high proportion of cysteine ions; almost 4
times that of the human proteomic average. This cysteine content could make parkin highly
tolerable to oxidation, and indeed, one group recently proposed that parkin is a possible
redox molecule (7). Parkin’s ability to directly reduce H2O2 in combination with its
proximity to mitochondria may act as a buffering shield and make it well suited as a redox
molecule. This chapter will elaborate on possibly essential consequences of parkin
oxidation, as a potential redox and signalling molecule.
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3.2 Materials and Methods
3.2.1 Selective Cysteine labelling with iodoacetamide and N-ethyl
maleimide
Protein samples (parkin, 141C) at 10 µM were exposed to 1 mM H2O2 for a total of 5 or 60
minutes and excess hydrogen peroxide was quenched with 5 mM ascorbic acid. Samples
were then denatured with EDTA and reacted with 50 mM iodoacetamide (IAA) to alkylate
free cysteines at 37 °C for 45 minutes. Excess IAA was quenched with 100 mM TCEP and
100 mM DTT, incubating at 37 °C for 45 minutes, while also reducing cysteines back to
the thiol form. Samples were then reacted with 300 mM N-ethyl maleimide (NEM), in
excess of reducing reagent, to label newly reduced cysteines at 37°C for 45 minutes.
Samples were then digested with Lys-C at 1:50 protein:Lys-C ratio at 37°C with shaking
for 3 hours, then Trypsin was added at a 1:30 ratio and incubated overnight. Samples were
analyzed by MS as described above, and data was processed using PEAKS software.

3.2.2 Circular Dichroism Spectroscopy
Circular dichroism spectroscopy experiments were performed using a JASCO J-810 CD
spectropolarimeter equipped with a Peltier temperature control. A 1 mm path length cuvette
was used. In all experiments, proteins were buffer exchanged into 100 mM NaCl, 25 mM
Tris, pH 8.0. All data were fit using GraphPad Prism to determine denaturation midpoint
as previously described.
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3.2.3 Zn2+ release analysis using Zincon
Protein samples were reacted in 100 µL volumes in buffer containing 50 mM CHES, pH
9.0. Samples contained either 10 µM parkin or 141C, with or without pUb in a 1:1 ratio.
40 µM Zincon was used for detection, and reactions were initiated with 5 mM H2O2.
Concurrent reactions were conducted to monitor the reaction on SDS-PAGE. Microplate
sample absorbance was measured using a Synergy H1 Microplate reader (Biotek) with
kinetic scanning at a wavelength of 620 nm. Absorbance data was converted to
concentration using Beer’s Law using an extinction coefficient for Zincon-Zn2+ complex
of 25050 M-1cm-1. The path length was determined using height of a 100 uL sample in a
well with a diameter of 6.94 mm, which equals a sample height of 0.28 cm. Data were
analyzed using Prism.

3.2.4 H2O2 Scavenging Assay using Amplex Red
The scavenging rate of parkin was determined by reacting residual hydrogen peroxide
(H2O2) with Amplex UltraRed (Thermo Fisher) in a horseradish peroxidase (HRP)
catalyzed reaction, and measuring fluorescence intensity of the resulting molecule,
resorfurin. Parkin, ubiquitin and catalase (CAT-SKL) were added in various concentrations
to 5 µM H2O2 in a 60 µL reaction volume. Samples were incubated for 30 minutes at room
temperature, at which point 50 µL of the reaction volume was added to 50 µL mixture
containing 100 µΜ Amplex UltraRed and 0.2 U/mL of HRP in a 96-well microplate. The
new mixture was incubated at room temperature for 15 minutes. Sample fluorescence
intensity was measured using a Synergy H1 microplate reader (Biotek) using settings for
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excitation wavelength of 530 nm and emission wavelength of 590 nm, as the
excitation/emission maxima are 568/581 nm for the Amplex UltraRed.

3.2.5 Ubiquitination assay.
Parkin was oxidized in the same manner as described in Chapter 2. Oxidized parkin
material was used in ubiquitination assays. These assays were monitored by a modified
recombinant ubiquitin containing an N-terminal cysteine residue labelled with DyLight
800 Maleimide (Ub800; Thermo Fisher Scientific) as previously described ((8, 9) All
reactions were performed at 37°C and contained 1 µM wild type or oxidized parkin, 0.5
µM UbcH7, 0.1 µM Uba1, 4 µM Ub, 0.5 µΜ pUb and 0.5 µM Ub800 in 5 mM MgATP,
50 mM HEPES (pH 7.5). The ubiquitination reactions were quenched with 3×SDS sample
buffer and 1 M DTT. 4–12% Bis-Tris gradient gels (Thermo Fisher Scientific) were used
with MES running buffer (250 mM MES, 250 mM Tris, 0.5% SDS and 5 mM EDTA, pH
7.3). Fluorescence intensity at 700 and 800 nm was measured using an Odyssey Imaging
System (LI-COR).
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3.3 Results
3.3.1 Cysteine labelling
The mass spectrometry results showed only a small proportion of cysteines being oxidized,
from as few as two in some cases and up to seven in the case of 141C. While parkin has 35
cysteines that may have varying degrees of exposure to solvent, we used a 2-step alkylation
protocol in tandem with mass spectrometry to examine which cysteines are more
susceptible to oxidation. Our protocol involved first oxidizing the protein in its native form
to preserve its natural conformation. The oxidation was then quenched, and the protein was
denatured and alkylated with IAA, creating a carbamidomethyl (CAM) adduct on any
cysteines that was unaffected by oxidation. By then reducing the protein then alkylating
with a second reagent, I was able to identify which cysteines were vulnerable to initial
oxidative modifications. When parkin was exposed to 1mM H2O2 for 5 minutes, the protein
digest was able to detect 335/465 residues of the sequence for full length parkin, which
covers 25/35 of cysteine residues. I was only able to detect C421 labelled with NEM
(Figure 3.1). However, when parkin was exposed to the same amount of H2O2 for 1 hour
we were unable to obtain the same amount sequence coverage of parkin, detecting 279/365
residues and three less cysteine residues. I was able to detect cysteine residues C166, 169,
C421, C436 and C441 labelled with NEM (Figure 3.2). It is interesting to note that while
these residues were the only ones detected with NEM within the entire sequence, they are
seemingly clustered together, with the former two being detected within 3 residues of each
other in the RING0 domain and the latter three occurring within the Rcat domain. When
the 141C construct was subjected to the same 1-hour long treatment at 1 mM H2O2, I was
only able to detect 172/325 residues and 22/35 cysteines. However, we were able to cover
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the majority of the Rcat domain, with the exception of a stretch of 13 resides from 443455. While only one residue was labelled with NEM, C441, it is consistent with the
cysteine residues that were oxidized in full-length parkin (Figure 3.3).
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Figure 3.1. Peptide coverage map of parkin exposed to 1 mM H2O2 for 5 minutes.
Parkin was exposed to 1 mM H2O2 for 5 minutes, alkylated with IAA, reduced with TCEP, then
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM)
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap Elite mass spectrometer
(ThermoFisher Scientific) and data were analyzed using PEAKS software.
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Figure 3.2. Peptide coverage map of parkin exposed to 1 mM H2O2 for 60 minutes.
Parkin was exposed to 1 mM H2O2 for 60 minutes, alkylated with IAA, reduced with TCEP, then
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM)
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap mass spectrometer (ThermoFisher
Scientific) and data were analyzed using PEAKS software.
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Figure 3.3. Peptide coverage map of 141C exposed to 1 mM H2O2 for 60 minutes.
141C was exposed to 1 mM H2O2 for 60 minutes, alkylated with IAA, reduced with TCEP, then
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM)
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap mass spectrometer (ThermoFisher
Scientific) and data were analyzed using PEAKS software.
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3.3.2 CD spectroscopy analysis
As cysteine-Zn2+ coordination is an essential component of parkin’s structure, we used CD
spectroscopy to analyze parkin’s dependence on cysteine oxidation state for structural
integrity. In our analysis, we measured the secondary structure content of wild type parkin,
parkin exposed to H2O2, and finally parkin in the presence of reducing agent for 1 and 3
hours after oxidation. Spectral analysis of untreated parkin between 200-280 nm revealed
local minima at 208 and 222 nm, typical of alpha helical structure. The minima present at
208 nm is much greater in magnitude, polarizing light approximately -30 mdeg, in
comparison to the minima at 222 nm, with an intensity of approximately -20 mdeg.
Interestingly, very little change occurred in parkin’s spectrum as a result of oxidation, with
possibly a very minor decrease in intensity at 222 nm. However, more dramatic changes
occur as a result of subsequent reduction, as the minima at 222nm decreases in intensity of
approximate 13 mdeg after exposure to reducing agent for 1 hour, and slight further
decrease after 3 hours of exposure.

71

Figure 3.4 CD spectroscopy analysis of parkin in various states of redox.
Parkin circular dichroism spectra from 200-280nm was measured for untreated parkin (black), parkin
oxidized with 5mM H2O2 for 5 minutes then quenched (red), then treated with 50 mM TCEP for 1 (orange)
and 3 hours (green). Experiments were performed using a JASCO J-810 CD spectropolarimeter equipped
with a Peltier temperature control. A 1 mm path length cuvette was used. All experiments were conducted
in buffer containing 100 mM NaCl, 25 mM Tris pH 8.0
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3.3.3 Parkin is a mild scavenger of reactive oxygen species
While our assays thus far have been designed to observe the consequences of oxidation on
parkin, in order to support our hypothesis of parkin as an effective scavenger of ROS, we
aimed to quantify the rate of H2O2 clearance. We used an Amplex UltraRed and horseradish
peroxidase (HRP) linked assay. HRP catalyzes a reaction between the Amplex reagent with
H2O2 in a stoichiometric 1:1 ratio, producing resorfurin, a fluorescent molecule. By
incubating increasing amounts of ubiquitin, parkin and catalase with hydrogen peroxide
for 30 minutes, we were able to assay the remaining amount of H2O2 after protein
reduction. As a negative control, ubiquitin was mostly redox inert and was only able to
decrease H2O2 from 5 µΜ to approximately 4 µΜ with up to 2 µΜ of ubiquitin added,
showing very little difference as a function of ubiquitin concentration. On the other hand,
catalase was used as a positive control was able to scavenge all H2O2 with 0.25 µΜ of
protein to virtually nothing. Interestingly parkin shows a moderate ability to scavenge
H2O2, and was able to clear approximately 1.5 µΜ of H2O2 with only 0.25 µΜ protein. This
effect is dose dependant, with parkin clearing almost 3 µΜ H2O2 when 2 µΜ of parkin was
added.
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Figure 3.5. Hydrogen peroxide scavenging assay.
Various concentrations of ubiquitin (black), parkin (red) and catalase (green) were incubated with 5 µΜ
H2O2 for 30 minutes. Residual H2O2 was then reacted with an Amplex UltraRed/HRP based assay to
generate resorfurin. Resofurin was monitored by fluorescence with excitation/emission values of 530/590
nm. Measurements were taking using a Synergy H1 microplate reader.
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3.3.4 Zn2+ ions are liberated in the presence of oxidation
As cysteines are critical in the coordination of Zn2+, I looked to quantify the dynamics of
Zn2+ release as a consequence of oxidation. I used Zincon, a Zn2+ binding reagent with a
measurable change in UV absorbance when in complex with a Zn2+. I was able to create
an` assay containing our protein of interest and Zincon in solution, and oxidation is initiated
by the addition of H2O2. Absorbance changes were monitored using a BioTek Synergy H1
microplate reader. I measured the change in Zincon-Zn2+ concentration of samples
containing 10 µM parkin or 141C, both in the presence and absence of phosphorylated
ubiquitin. For wild type parkin, we observed a sigmoidal curve with an inflection point
approximately 20 minutes into the reaction. The curve reaches a maximum of 20 µM
released Zn2+. Parkin is capable of binding 8 Zn2+ ions per protein molecule so
stoichiometrically, 10 µM of parkin will contain 80 µM of Zn2+. The release of 20 µM of
Zn2+ ions corresponds to the liberation of 2 Zn2+ per parkin molecule. The binding curve
reaches saturation and is maintained for at least 30 minutes (Figure 3.6A). While in the
presence of pUb, there was no distinguishable difference in Zn2+ release rates as error bars
overlapped.
When 141C was tested, the inflection point occurred earlier at approximately 15
minutes, in comparison to the full-length parkin. Interestingly, the addition of pUb was
able to slow down the rate of Zn2+ liberation, causing each curve to inflect approximate 3
minutes later than usual (Figure 3.6B).
While the reactions occurred, samples were taken to track using SDS-PAGE.
Interestingly, while the protein was oxidized at 5 mM H2O2, the rate of protein precipitation
was dramatically decreased, parkin remained detectable, albeit in purely a high molecular

75

weight form, throughout the entire 2 hours reaction (Figure 3.6C). This is in contrast to
parkin oxidation in the absence on Zincon/ Zn2+ scavenging (Figure 2.4C).

Figure 3.6. Zn2+ release assay of Parkin and 141C.
10 µM of Parkin (A) and 141C (B) were oxidized in 5 mM H2O2 in the presence of Zn2+on. pUb was
added in a 1:1 ratio for both proteins (red), or was absent (black). An SDS-PAGE gel of parkin being
oxidized at 5 mM over a 2 hour time course to monitor oxidation.
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3.3.5 Parkin ubiquitination activity is abolished in oxidizing conditions.
While thus far I have established the structural consequences of parkin oxidation, I have
yet to examine the effect of oxidation on the primary function of parkin as an E3 ubiquitin
ligase (Figure 3.7). Methods for analyzing parkin’s ubiquitination activity has been well
established (8). By providing parkin with Uba1, UbcH7, ATP, Ub and pUb, parkin will
have access to all the components required to ubiquitinate a substrate. In order to visualize
this reaction, a proportion of Ub is labelled with a fluorescent dye, allowing us to detect
ubiquitination in the form of free and parkin-attached polyubiquitin chains, which is
observed by a laddering pattern as ubiquitin is sequentially attached. The laddering
eventually becomes a smear as resolution becomes lower in higher molecular weight
ranges. By exposing parkin to 5 mM H2O2 then quenching the oxidation, I was able to
obtain a series of increasingly oxidized parkin protein, similar to Figure 2. Each form of
parkin was used in a ubiquitination assay to test the ability to ubiquitinate a substrate, in
this case another parkin molecule, after exposure to oxidation. As expected, I observed
ubiquitination activity in the unoxidized parkin as indicated at time = 0 min. Interestingly,
I was able to observe a slight increase in ubiquitination when parkin was oxidized for 2
minutes. This activity remains slightly elevated but tapers off at the 15-minute time point,
at which point the activity is comparable to that of the unoxidized protein. After 30 minutes
of oxidation, parkin is no longer active.
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Figure 3.7. Ubiquitination assay with parkin oxidized at various time points.
Parkin, was pre-oxidized and used in a functional ubiquitination assay. Protein ubiquitination is indicated
by sequentially increasing steps, indicating ubiquitination addition onto parkin. Time refers to the length
of time parkin was exposed to 5 mM H2O2.
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3.4 Discussion
Oxidation of parkin peptides has been previously established (4) with the limitation that
only peptides that contained sulfonation were detected. Our mass spectrometry data also
showed a total of 5 distinct cysteine residues that were vulnerable to oxidation, as
evidenced by a very small cluster of cysteine residues exhibited NEM modifications
surrounding the catalytic cysteine, C431 and a pair of cysteines in the RING0 domain.
Interestingly, across all three oxidation experiments, C432 was not shown to be oxidized
in any scenario (Figure 3.1-3.3). This comes as a surprise as previous data has shown the
C431 is indeed solvent accessible (10). This may indicate that the catalytic cysteine is more
resistant to oxidation. While oxidation has previously been shown to abolish parkin
function (4), and is corroborated by data I present here, the mechanism in which this occurs
must not directly affect the catalytic cysteine, and must instead be the cause of a structural
collapse. Indeed, the C166 and C169 coordinate the same cysteine, as do C421, C436 and
C441. This suggest a Zn2+ site targeted cascade of oxidation, were oxidation of one residue
may then cause collapse of that coordination site and render other residues vulnerable to
oxidation. However, the RING0 and Rcat domains remains highly vulnerable to oxidation,
which would compromise structural integrity due to loss Zn2+ ion coordination.
The overall structure as analyzed by CD spectropolarimetry was interesting. The
untreated parkin had a very similar spectrum to that of the oxidized parkin; changes were
not visible until we started to reduce the protein. There was a loss of alpha helical structure
after reduction with TCEP. A previous study has established a correlation between alpha
helical structure content and 222/208 ratio; where a ratio of 1.1 or greater is diagnostic of
coiled-coils, while a ratio of 0.9 or less indicates more isolated helix structure (11). The
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distinct loss of the intensity at 222 nm as a result of reduction is consistent with the loss of
a coiled coil structure (Figure 3.4). Overall, this may indicate that mild oxidation was
beneficial to the structure and function of parkin, similar to DJ-1, another PD implicated
protein that requires oxidation in order to be fully activated (12). This is supported by our
ubiquitination activity assay (Figure 3.7), where initial oxidative insult to parkin caused
an increase in ubiquitination activity. While it is proposed that DJ-1 utilizes the oxidation
of its cysteine thiol to a sulfinic acid as a molecular redox switch, parkin may utilize the
conveniently available oxidation that it is exposed to during activation to further augment
the activation signal.
We then compared parkin’s ability to act as a redox scavenger of H2O2.
Unsurprisingly, catalase was able to clear all H2O2 at our lowest tested concentration.
However, parkin, when compared to the relatively redox-inert ubiquitin, was able to clear
a greater than 1:1 ratio of parkin to hydrogen peroxide. While we may expect more of
parkin, given the fact it contains 35 cysteines, the proof of principle may apply in a much
more chronic, long term exposure as would be relevant in PD. While our experiments could
have utilized smaller H2O2 concentrations for longer time points, the time-scale is several
orders of magnitudes shorter than parkin would be subjected to in a pathological PD
patient.
Interestingly, few studies have been conducted with regards to parkin-Zn2+ release
as a result of oxidation. The importance of parkin’s Zn2+ content is underscored by the fact
that not only does parkin coordinate an impressive 8 Zn2+, but that Zn2+ is considered the
most sensitive redox-inert ion signalling molecules (5). Our data showed only two Zn2+
were liberated as a result of parkin oxidation (Figure 3.6). In only 2 Zn2+ can be released
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from parkin via oxidation, this will put parkin within the realm of other metalloproteins
and likely not result in extensive Zn2+ mediated signalling. However, the possible release
of all of parkin’s ions indicate the potential for a physiologically significant role in Zn2+
signalling. Interestingly, when monitoring our Zn2+ release assay with SDS-PAGE we
observed a dramatically slower oxidation rate in comparison to our initial oxidation assays
(Figure 2.3C). We propose that Zincon, which is capable of binding and sequestering free
Zn2+ ions, is acting in a Zn2+ buffering capacity in our reaction. While previous protein
precipitation was attributed to the loss of Zn2+ coordination, a possible mechanism is free
Zn2+ negatively impacting the protein structure.
We have thus far demonstrated two possible novel functions of parkin as both a
redox molecule and a redox sensitive Zn2+containing protein. Also, we have shown that the
catalytic cysteine is not preferentially oxidized (Figure 3.1-3.3). Interestingly, parkin
exhibits an increase in activity when oxidized for a short time frame, and then the function
is lost, presumably due to oxidative damage. These results are consistent with another
study which displayed parkin upregulation after exposure to H2O2 in vivo (4). While the in
vivo study rationalized the upregulation of parkin as a mechanism due to initial
mitochondrial signalling and subsequent recruitment and activation of parkin, our
experiment was conducted in vitro, which may suggest a molecular mechanism of parkin
activation as a result of oxidation. While oxidation would certainly hinder cysteine
function, parkin still contains 4 cysteine residues that are not known to be catalytic or
structural. This could indicate an oxidation mediated stabilization of activation of parkin
that mirrors that of DJ-1, which has been shown to have a highly conserved cysteine residue
that is required to confer a neuroprotective function.
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Chapter 4

4

Summary of Thesis

4.1 Parkin is a redox sensitive molecule
The oxidation of parkin has provided insight into several interesting possibilities in its
cellular function. While PINK1/parkin has been established as one of primary pathways
leading to mitochondrial degradation (1), little is known about the pathogenesis of PD
when these proteins are affected. Parkin oxidation has shown form reversible high
molecular weight oligomers (Figure 2.3), which are mediated by disulfide linkages. This
process has been shown to followed an ordered pathway, as oxidation cause parkin
oligomers to sequentially grow over time (Figure 2.10). Studies have shown an association
of parkin to the periphery of LB’s (2), and although extensive oxidation causes the
formation of insoluble oligomers, the reducibility of these oligomers would distinguish
them from the true fibrillar aggregates of SNCA that make up the majority of LB’s.
Assessment of LB’s content may be subject to further proteomic analysis, and whether or
not the proteins in LB’s are extensively oxidized. The oxidation of parkin has been shown
to cause disulfide linked oligomerization, which eventually proceeds to insolubility. The
formation of insoluble fibril-like aggregates is eerily similar to the aggregation mechanism
of SNCA which may suggest a mechanistic of parkin implication in LB’s. The similarity
of these aggregates to SDS-resistant aggregates found in Huntington’s disease (Figure
2.8), another neurodegenerative disease is possible evidence of parkin’s’ involvement in
neuronal plaque formation. Interestingly, we observed that parkin maintains solubility
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when oxidized in the presence of a zinc binding reagent (Figure 3.6B). This could possibly
allude to a zinc toxicity mechanism that promotes insolubility of proteins.
While parkin may primarily function as an E3 ligase to signal mitophagy, we
suspect that parkin exposure to oxidation would necessitate a structure that is redox
tolerant, and that parkin may also have to function as a redox scavenger. Ubiquitination
activity is upregulated for a short time frame after exposure to oxidation. While this is
consistent with a study displayed parkin upregulation after exposure to H2O2 in vivo (3),
our experiment was done without the cellular context required for protein activation.
Therefore, our in vitro study is suggestive of an isolated, molecular cause of parkin
activation. Another PD-implicated gene is the DJ-1 protein, which very readily converts
its Cys106 to a Cys106-sulfonate (Cys106-SO3-) (4). This conversion stabilizes DJ-1 as the
sulfonate side chain forms three hydrogen bonds to surrounding residues (5). Parkin
contain four additional cysteine residues that do not participate in catalysis or Zn2+
coordination, and could possibly function as a redox sensitive module for further parkin
stabilization. This stabilization could possibly be used to mediate favorable interaction
between parkin and UbcH7, Ub or pUb.
As parkin is able to be oxidized beyond the point of function loss (Figure 2.3, 3.7)
we explored the possibility of parkin as a redox molecule. Considering both the localization
and high cysteine content of parkin, it would be well suited as a convenient, non-enzymatic
source of redox molecules. The comparing the efficacy of H2O2 clearance rates of parkin
to ubiquitin, parkin is able to at least clear H2O2 at close to a 1:1 ratio, while ubiquitin was
mostly redox-resistant. However, our assay was limited by the range of H2O2 clearance
when compared to catalase, which was able to immediately deplete all H2O2 almost
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immediately at all concentrations tested (Figure 3.5). Further analysis of the effective
range of parkin’s H2O2 scavenging ability should be conducted.

4.2 Oxidative consequences of Zn2+ liberation
The structural and functional consequences of parkin oxidation have been studied in the
past and elaborated upon in this study, however we look at a novel concept of parkin.
Parkin’s ability to coordinate eight Zn2+ ions was partially abolished as a result of oxidation
(Figure 3.6A-B), causing the release of two Zn2+ ions per molecule of parkin.
Concurrently, we have shown that oxidation also causes a degradation of coiled-coil
structure (Figure 3.4). Taken together, we can postulate that a coordinated coiled coil
structure may be essential for at least 2 Zn2+ coordination. As we can also detect a slight
upregulation of parkin ubiquitination activity (Figure 3.7). If the local concentration of
parkin at the mitochondrial periphery high enough, this could cause a significant increase
in free Zn2+ ion concentration. This is supported by the fact that Zn2+ ion signalling is
extremely sensitive, operating at free ion concentration between 10-9 and 10-12 M. This
range is dramatically lower than that of either Ca2+ and Mg2+ by factors of 1000 and
1000000, respectively. Zn2+ is also a redox inert ion, which would be advantageous in a
redox sensitive molecular signalling system.

4.3 Future directions
The research outlined in this thesis aimed to explore novel functions of parkin: specifically,
the ability to act as a ROS scavenger and a potential Zn2+ signalling molecule. While the
currently established function of parkin is to act as an E3 ligase to induce mitophagy,
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structural components of parkin including high cysteine and Zn2+ content, in addition to its
localization to the periphery of the mitochondria could have certain implications for the
overall health of the cell. We discuss parkin’s ROS scavenging efficacy, but were limited
by the overall effective range of H2O2 clearance. As there is a massive disparity between
the H2O2 clearance rates of parkin and catalase, does not possibly diminish parkin’s
contribution as an anti-oxidant. We suggest that further studies may quantify the rates of
H2O2 clearance to demonstrate a physiologically relevant level that would be beneficial. In
vivo studies could also be conducted with special regard to clearly delineating between
parkin ligase activity and direct redox potential, potentially through the use of a
catalytically dead mutant.
While parkin oxidation also results in Zn2+ ion liberation, it would be crucial to
quantify the flux of free Zn2+ ions and whether the signal was significant enough to elicit a
response. Further research into the cellular effects of zinc increase should be conducted to
assess whether these activated pathways have a synergistic effect in either mitochondrial
clearance, rescue from oxidative stress or even cellular apoptosis. This discovery could
establish multiple function of parkin as a redox molecule as well as a reserve of Zn2+ ions.
We propose that a possible mechanism where mitochondrial depolarization and subsequent
ROS generation exceeds the cells ability to carry out mitophagy. In this situation, activated
parkin that is recruited to the mitochondria can carry out a “sacrificial lamb” function,
consuming itself as a redox molecule and in the process cause a significant increase of free
Zn2+ ions.
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4.4 Significance of Work
As of the date of this study, only speculation exists on how the manifestation of PD occurs.
In this study, we provide a possible mechanism of parkin aggregation and promotion of LB
formation, which may provide insight into the development of PD. As our study especially
focussed on the structural and functional consequences of parkin oxidation in PD, this may
provide valuable insight into antioxidant-based therapies in order to combat or delay the
onset of PD. Furthermore, we provide plausible, novel mechanisms of parkin, which may
supplement the well-established ligase activity of parkin and set the foundation for research
beyond what is already known.

87

4.5 References
1. Sato, S., and Furuya, N. (2018) Induction of PINK1/Parkin-Mediated Mitophagy. in
Mitophagy: Methods and Protocols (Hattori, N., and Saiki, S. eds), pp. 9–17, Methods
in Molecular Biology, Springer, New York, NY, 10.1007/7651_2017_7
2. Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L.,
Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., Langston, J. W., Mizuno, Y.,
Hyman, B. T., Selkoe, D. J., and Kosik, K. S. (2002) Parkin Localizes to the Lewy
Bodies of Parkinson Disease and Dementia with Lewy Bodies. Am J Pathol. 160,
1655–1667
3. Meng, F., Yao, D., Shi, Y., Kabakoff, J., Wu, W., Reicher, J., Ma, Y., Moosmann, B.,
Masliah, E., Lipton, S. A., and Gu, Z. (2011) Oxidation of the cysteine-rich regions
of parkin perturbs its E3 ligase activity and contributes to protein aggregation.
Molecular Neurodegeneration. 6, 34
4. Wilson, M. A. (2011) The role of cysteine oxidation in DJ-1 function and dysfunction.
Antioxid. Redox Signal. 15, 111–122
5. Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C.,
Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., and Cookson, M. R.
(2004) The Parkinson’s disease protein DJ-1 is neuroprotective due to cysteinesulfinic acid-driven mitochondrial localization. PNAS. 101, 9103–9108

88

Curriculum Vitae
AN (RICHARD) TRAN
EDUCATION
Master of Science, Biochemistry (Shaw Lab)
The University of Western Ontario (Western), London, Ontario

2017-Present

Thesis based Masters candidate investigating the role of oxidative stress in the
development of Parkinson’s disease. The project involves the utilization of
biophysical techniques such as Nuclear Magnetic Resonance to study the
structure of the parkin protein
Relevant Courses: Modern Applications of Biological NMR spectroscopy
9525R, Scientific Writing 9501Q, Chemical Biology 9703R
Poster Presentations on The Role of Oxidative Stress on Parkin’s Structure
Fall Graduate Research Symposium
London Health Research Day

Oct 2017
May 2018

Bachelor of Medical Science (Honors Specialization in Biochemistry)
2013-2017
The University of Western Ontario (Western), London, Ontario
Thesis: Exploring Parkin’s Linker Region
Relevant Courses: Human Physiology 2130; Biochemistry Lab 3380;
Biochemical Macromolecules 3381A; Biochemical Regulation
3382A; Advanced Methods for Biochemistry 3390; Clinical
Biochemistry 3386G; Mammalian Histology 3309; Systemic Human
Anatomy 3319; Cellular Physiology 3140; Molecular Biology of
DNA & RNA 4410A; Molecular Biology of Proteins 4420A, Genetic
Engineering 3593B; Molecular Genetic of Human Cancer 4450A;
Applications of Synthetic Biology and Chemical Genetics in
Medicine 4415B; Proteomics and Protein Biotechnology 4425B;
Research Project and Seminar 4483E
RESEARCH EXPERIENCE
Lab Volunteer (Edgell Lab)
Jan 2016 – Apr 2016
The University of Western Ontario, London, Ontario
Assistant lab volunteer to graduate students, familiarity with UV imaging,
autoclaving, sterile technique, gel electrophoresis, protein purification and
general lab technique.

89

Biochemistry 3380G Laboratory Student
Jan 2016 – Apr 2016
The University of Western Ontario, London, Ontario
Conducted experiments and concisely wrote scientific report on hemoglobin
oxidation and introduction of novel mutation in EGFP to alter its fluorescence.
Clearly articulated the significance of our study, information, methods, results,
discussion and future studies of experiments involving EGFP.
Bachelor’s Honors Thesis Project
Sept 2016 - Apr 2017
The Shaw Lab, The University of Western Ontario, London, Ontario
Conducted research on yet-to-be elucidated region in the parkin protein
Conducted experiments such circular dichroism spectroscopy with related data
analysis, NMR spectroscopy both 2D and 3D. Also familiar with using NMR
related software and scripts to process data including VnmrJ and nmrDraw.
Thesis Paper: Exploring Parkin’s Linker Region
VOLUNTEER
Event Assistant
May 2018
London District Science Olympics, London, ON
Provided assistance in running several events for Science Olympics
Managed secondary school students, ensuring timely arrival and starting of
events throughout the day
Volunteer Judge
April 2019

April 2018,

Thames Valley Science & Engineering Fair, London, ON
Judged elementary students’ science posters and presentations
Participated in team-based judging with active discussion to come to a
compromising
final decision for 1st 2nd and 3rd place

SCHOLARSHIP AND ACADEMIC HONOURS
Western Scholarship of Distinction

2013

CERTIFICATION AND TRAINING
Biosafety Training
Comprehensive WHIMIS Certification
Lab Safety and Hazardous Waste Management

90

2016
2016
2016

